NHS increases funding for inclisiran although uptake remains ‘slower than expected’

NHS England has increased funding for inclisiran (Leqvio; Novartis), with community pharmacies now able to purchase the anticholesterol drug at a nominal charge of £45 and be reimbursed at £60 — an increase from £50. In a letter on cardiovascular disease (CVD) prevention sent to NHS colleagues on 31 March 2025, NHS England said the […]